Theriva Biologics Statistics Share Statistics Theriva Biologics has 9.06M
shares outstanding. The number of shares has increased by 569.14%
in one year.
Shares Outstanding 9.06M Shares Change (YoY) 569.14% Shares Change (QoQ) 225.59% Owned by Institutions (%) n/a Shares Floating 8.96M Failed to Deliver (FTD) Shares 34 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 95.18K, so 1.05% of the outstanding
shares have been sold short.
Short Interest 95.18K Short % of Shares Out 1.05% Short % of Float 1.05% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.09 and the forward
PE ratio is -0.09.
Theriva Biologics's PEG ratio is
0.
PE Ratio -0.09 Forward PE -0.09 PS Ratio 0 Forward PS 0.1 PB Ratio 0.12 P/FCF Ratio -0.14 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Theriva Biologics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.15,
with a Debt / Equity ratio of 0.08.
Current Ratio 2.15 Quick Ratio 2.15 Debt / Equity 0.08 Debt / EBITDA -0.06 Debt / FCF -0.09 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.28M Employee Count 20 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -93.38% in the
last 52 weeks. The beta is 0.82, so Theriva Biologics's
price volatility has been higher than the market average.
Beta 0.82 52-Week Price Change -93.38% 50-Day Moving Average 0.47 200-Day Moving Average 1.16 Relative Strength Index (RSI) 55.11 Average Volume (20 Days) 1,490,888
Income Statement
Revenue n/a Gross Profit n/a Operating Income -26.35M Net Income -25.65M EBITDA -26.35M EBIT -25.65M Earnings Per Share (EPS) -19.03
Full Income Statement Balance Sheet The company has 11.61M in cash and 1.56M in
debt, giving a net cash position of 10.04M.
Cash & Cash Equivalents 11.61M Total Debt 1.56M Net Cash 10.04M Retained Earnings -334.97M Total Assets 32.16M Working Capital 4.33M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.94M
and capital expenditures -1K, giving a free cash flow of -16.94M.
Operating Cash Flow -16.94M Capital Expenditures -1K Free Cash Flow -16.94M FCF Per Share -12.56
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TOVX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TOVX is $6,
which is 1150% higher than the current price. The consensus rating is "Buy".
Price Target $6 Price Target Difference 1150% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 26, 2024. It was a
backward
split with a ratio of 1:25.
Last Split Date Aug 26, 2024 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -16.36 Piotroski F-Score 2
